Cullen Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Sell
110,982
-1,757
-2% -$206K 1.73% 14
2026
Q1
$13.6M Sell
112,739
-4,884
-4% -$564K 1.79% 13
2025
Q4
$13M Sell
117,623
-11,693
-9% -$1.1M 1.69% 12
2025
Q3
$11.5M Buy
129,316
+8,890
+7% +$732K 1.53% 14
2025
Q2
$9.53M Buy
120,426
+10,237
+9% +$814K 1.35% 20
2025
Q1
$9.89M Buy
110,189
+12,128
+12% +$1.13M 1.5% 17
2024
Q4
$9.76M Buy
98,061
+2,084
+2% +$215K 1.44% 18
2024
Q3
$10.9M Buy
95,977
+3,036
+3% +$361K 1.63% 16
2024
Q2
$11.5M Buy
92,941
+751
+0.8% +$96.7K 1.83% 12
2024
Q1
$12M Buy
92,190
+2,645
+3% +$326K 1.89% 8
2023
Q4
$9.76M Buy
+89,545
New +$9.29M 1.71% 13

Other funds holding MRK

Cullen Investment Group's MRK Position: Q2 2026 in Review

Cullen Investment Group reduced its Merck (MRK) stake by 1.6% in Q2 2026, selling an estimated $206K and leaving 110,982 shares worth $14.3M. The position accounts for 1.73% of the portfolio, ranked #14.

Cullen Investment Group first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cullen Investment Group held 110,982 shares of Merck worth $14.3M as of Q2 2026.
  • Cullen Investment Group sold 1,757 Merck shares in Q2 2026, an estimated $206K.
  • Merck made up 1.73% of Cullen Investment Group's portfolio in Q2 2026, its #14 holding.
  • Cullen Investment Group first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cullen Investment Group's 13F filing for Q2 2026, filed 9 Jul 2026.